The current consensus in the medical community is that while rosuvastatin and other statins show potential anti-cancer properties, the evidence is not strong enough to recommend their use specifically for cancer prevention or treatment outside of clinical trials. Ongoing and future research will be crucial in determining the true efficacy and safety of rosuvastatin in this context.
